Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy

European Journal of Haematology

Volumn 61, Issue 1, 1998, Pages 14-20

  Sala, Roberta ^a   Mauro, Francesca R ^a   Bellucci, Roberto ^a   De Propris, Maria Stefania ^a   Cordone, Lole ^a   Lisci, Alessandro ^a   Foà, Robin ^b   De Fabritiis, Paolo ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Institute of Haematology   (Italy)

Author keywords

C034+ cells; Chlorambucil; CLL; Fludarabine; Haemopoietic progenitors

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CHRONIC LYMPHATIC LEUKEMIA; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031866458     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01055.x     Document Type: Article

References (26)

1. SAWITSKY A, RAI KR, GILDWELL Q, SILVER RT. Comparison of daily versus intermittent chloramhucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977: 50: 1049-1059
2. GREVER MR, KOPECKY KJ, COLTMA CA, et al. Fludarahine monophosphate: A potentially useful agent in chronic lymphocytic leukemia. New Rev Fr Hematol 1988: 30: 457-459.
3. O'BRIEN S, KANTARJIAN H, SERAN M, et al. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis derived prognostic model for response to treatment. Blood 1993: 82: 1695-1700.
4. KEATING MJ. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol 1990: 17: 49-62.
5. ROBERTSON LE, HUH YO, BUTLER JJ, et al. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood 1992: 80: 29-36.
6. TSATALAS C, CHALKIA P, ATHANASIADIS G, et al Increased pheripheral blood normal myeloid progenitor cells (CFUGM) in chronic lymphocytic leukaemia: a perspective for autologous peripheral blood stem cell transplantation. Eur J Haematol 1995: 54: 235-240.
7. SCALZULLI PR, MUSTO P, DELL' OLIO M, CAROTENUTO M. CFU - GM are not increased in peripheral blood of patients with chronic lymphocytic leukaemia. Eur J Haematol 1996: 57: 180-181.
8. BINET JL, CATOVSKY D, DIGHIERO G, et al. International Workshop on chronic lymphocytic leukemia: chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989: 110: 236-238.
9. BINET JL, AUQUIER A, DIGHIERO G, et al. A new prognostic classification of chronic lymphocyte leukemia derived from a multivariate analysis. Cancer 1981: 48: 198-206.
10. MONTSERRAT E, VINOLAS N, REVERTER JC, ROZMAN C. Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988: 30: 359-361.
11. LEE JS, DIXON DO, KANTARJIAN HM, KEATING MJ, TALPAZ M. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 1987: 69: 929-936.
12. MONTSERRAT E, GOMIS F, VALLESPI T, et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991: 78: 1545-1551.
13. SANDOVAL. A, PLUNKETT W. Inhibition of UV-induced DNA repair in quiescent human peripheral blood lymphocytes by fludarabine stimulates apoptosis. Proc Am Assoc Cancer Res 1994: 35: Abstract 2353.
14. HUANG P, PLUNKETT W. Fludarabine - and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother Pharmacol 1995: 36: 181-188.
15. KEATING MJ, O' BRIEN S, KANTARJIAN H, et al. Long-term follow up in patients with chronic lymphocytic leukemia treated with fludarabine as single agent. Blood 1993: 81: 2878-2884.
16. KEATING MJ. KANTARJIAN H, TALPAZ M, et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989: 74: 19-25.
17. KEATING MJ, KANTARJIAN H, O'BRIEN S, et al. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol 1991: 9: 44-49.
18. MICHALLET M, CORRONI B, HOLHARD D, et al. Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG. Bone Marrow Transplant 1991: 7: 275-279.
19. RABINOWE SN, SOIFFER RJ, GRIBBEN JG, et al. Autologous and allogenic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993: 82: 1366-1376.
20. KHOURI IF. KEATING MJ, VRIESENDORP HM, et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994: 12: 748-758.
21. MICHALLET M, ARCHIMBAUD E, ROWLINGS PA, et al. Hematopoietic stem cell transplant for chronic lymphocylic leukemia. Bone Marrow Transplant 1996: 17 (abstr 55).
22. MELONI G, MAURO FR, GUGLIELMI C, et al. Peripheral blood stem cell transplanlation in CLL patients in remission after fludarabine therapy. A feasibility study. Bone Marrow Transplant 1996: 17: (abstr 465).
23. BASTION Y, FELMAN P, DUMONTET C, ESPINOUSE D, COIFFIER B. Intensive radio-chemotherapy with peripheral blood stem cell transplantation in young patienls with chronic lymphocytic leukemia. Bone Marrow Transplant 1992: 10: 467-468.
24. GRIBBEN JG, BARLETT-PANDITF L. PROVAN A, et al. Disease free status and absence of PCR detectable minimal residual disease suggest eradication of B-CLL following autologous and allogeneic BMT. Blood 1995: 86 (suppl 1): abstr 1815.
25. ESTROV Z, ZIPF TF, O'BRIEN S, et al. Identification of chronic lymphocytic leukemia (CLL) progenitor cells: Blood 1994: 84 (suppl 1): abstr 1816.
26. + cells of patients with B-cell chronic lymphocytic leukemia. Blood 1997: 89: 4275-4281.